Chief Executive Officer
Mr. Meaney joined The Zuellig Group in 2004 as Chief Executive Officer. more>
Prior to his
appointment at Zuellig
, Mr. Meaney
worked in a number of turnaround situations, including: the chief commercial officer at Swiss International Airlines
in Zurich; executive vice president at South African Airways
in Johannesburg; and the chief executive officer of South African Vaccine Producers
, a parastatal pharmaceutical manufacturer based in Johannesburg.
Prior to his taking on leadership roles in international groups, he was a strategic consultant with Strategic Planning Associates (now part of Oliver Wyman) based in London and in Geneva where he worked in a variety of industries.
Before beginning his career in business, Mr. Meaney served as a CIA operations officer.
He also serves on the board of Moksha8, a private pharmaceutical company controlled by TPG.
Additionally, he is a trustee of both Carnegie Mellon University as well as Rensselaer Polytechnic Institute.
He has a B.S. degree in Mechanical Engineering from Rensselaer and an MBA from Carnegie Mellon University in Pittsburg, Pennsylvania.
holds U.S., Swiss, and Irish nationalities.